Article
Reliable genotypic tropism tests for the major HIV-1 subtypes.
Scientific reports - 25 Feb 2015
Cashin Kieran, Gray Lachlan R, Harvey Katherine L, Perez-Bercoff Danielle, Lee Guinevere Q, Sterjovski Jasminka, Roche Michael, Demarest James F, Drummond Fraser, Harrigan P Richard, Churchill Melissa J, Gorry Paul R
Abstract excerpt
Over the past decade antiretroviral drugs have dramatically improved the prognosis for HIV-1 infected individuals, yet achieving better access to vulnerable populations remains a challenge. The principal obstacle to the CCR5-antagonist, maraviroc, from being more widely used in anti-HIV-1 therapy regimens is that the pre-treatment genotypic "tropism tests" to determine virus susceptibility to maraviroc have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
